Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 15, 2017

Reference ranges of thromboelastometry in healthy full-term and pre-term neonates

  • Rozeta Sokou , Leontini Foudoulaki-Paparizos , Theodore Lytras , Aikaterini Konstantinidi , Martha Theodoraki , Ioannis Lambadaridis , Antonis Gounaris , Serena Valsami , Marianna Politou , Argyri Gialeraki , Georgios K. Nikolopoulos , Nicoletta Iacovidou , Stefanos Bonovas and Argirios E. Tsantes EMAIL logo

Abstract

Background:

Rotational thromboelastometry (ROTEM) is an attractive method for rapid evaluation of hemostasis in neonates. Currently, no reference values exist for ROTEM assays in full-term and pre-term neonates. Our aim was to establish reference ranges for standard extrinsically activated ROTEM assay (EXTEM) in arterial blood samples of healthy full-term and pre-term neonates.

Methods:

In the present study, EXTEM assay was performed in 198 full-term (≥37 weeks’ gestation) and 84 pre-term infants (<37 weeks’ gestation) using peripheral arterial whole blood samples.

Results:

Median values and reference ranges (2.5th and 97.5th percentiles) for the following main parameters of EXTEM assay were determined in full-term infants: clotting time (seconds), 41 (range, 25.9–78); clot formation time (seconds), 70 (range, 40–165.2); maximum clot firmness (mm), 66 (range, 41–84.1); lysis index at 60 min (LI60, %), 97 (range, 85–100). The only parameter with a statistically significant difference between full-term and pre-term neonates was LI60 (p=0.006). Furthermore, it was inversely correlated with gestational age (p=0.002) and birth weight (p=0.016) in pre-term neonates.

Conclusions:

In conclusion, an enhanced fibrinolytic activity in pre-term neonates was noted. For most EXTEM assay parameters, reference ranges obtained from arterial newborn blood samples were comparable with the respective values from studies using cord blood. Modified reagents, small size samples, timing of sampling, and different kind of samples might account for any discrepancies among similar studies. Reference values hereby provided can be used in future studies.


Corresponding author: Argirios E. Tsantes, MD, PhD, Laboratory of Haematology and Blood Bank Unit, “Attiko” Hospital, School of Medicine, National and Kapodistrian University of Athens, 1 Rimini Street, 12462 Athens, Greece, Phone: +30 210 5831765, Fax: +30 210 5831770

Acknowledgments

The authors would like to acknowledge their colleague, the late Leontini Foudoulaki-Paparizos, for her invaluable support and contribution to the design and conduct of this study.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Luddington RJ. Thromboelastography/thromboelastometry. Clin Lab Haematol 2005;27:81–90.10.1111/j.1365-2257.2005.00681.xSearch in Google Scholar PubMed

2. Haizinger B, Gombotz H, Rehak P, Geiselseder G, Mair R. Activated thrombelastogram in neonates and infants with complex congenital heart disease in comparison with healthy children. Br J Anaesth 2006;97:545–52.10.1093/bja/ael206Search in Google Scholar PubMed

3. Osthaus W, Boethig D, Johanning K, Rahe-Meyer N, Theilmeier G, Breymann T, et al. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis 2008;19:220–5.10.1097/MBC.0b013e3282f54532Search in Google Scholar PubMed

4. Radicioni M, Mezzetti D, Del Vecchio A, Motta M. Thromboelastography: might work in neonatology too? J Matern Fetal Neonatal Med 2012;25:18–21.10.3109/14767058.2012.714996Search in Google Scholar PubMed

5. Strauss T, Levy-Shraga Y, Ravid B, Schushan-Eisen I, Maayan-Metzger A, Kuint J, et al. Clot formation of neonates tested by thromboelastography correlates with gestational age. Thromb Haemost 2010;103:344–50.10.1160/TH09-05-0282Search in Google Scholar PubMed

6. Edwards RM, Naik-Mathuria BJ, Gay AN, Olutoye OO, Teruya J. Parameters of thromboelastography in healthy newborns. Am J Clin Pathol 2008;130:99–102.10.1309/LABNMY41RUD099J2Search in Google Scholar PubMed

7. Cvirn G, Gallistl S, Kutschera J, Wagner T, Ferstl U, Jurgens G, et al. Clot strength: a comparison between cord and adult blood by means of thrombelastometry. Pediatr Hematol Oncol 2008;30:210–3.10.1097/MPH.0b013e318162bd2cSearch in Google Scholar PubMed

8. NCCLS. How to define and determine reference intervals in the clinical laboratory; approved guideline, 2nd ed. Wayne, PA: NCCLS, 2000. NCCLS document C28-A2.Search in Google Scholar

9. R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing, 2016. Available at: http://www.R-project.org.Search in Google Scholar

10. Sidlik R, Strauss T, Morag I, Shenkman B, Tamarin I, Lubetsky A, et al. Assessment of functional fibrinolysis in cord blood using modified thromboelastography. Pediatr Blood Cancer 2016;63:839–43.10.1002/pbc.25865Search in Google Scholar PubMed

11. Oswald E, Stalzer B, Heitz E, Weiss M, Schmugge M, Strasak A, et al. Thromboelastometry (ROTEM) in children: age-related reference ranges and correlations with standard coagulation tests. Br J Anaesth 2010;105:827–35.10.1093/bja/aeq258Search in Google Scholar PubMed

12. Saxonhouse MA, Manco-Johnson MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009;33:52–65.10.1053/j.semperi.2008.10.007Search in Google Scholar PubMed

13. Parmar N, Albisetti M, Berry LR, Chan AK. The fibrinolytic system in newborns and children. Clin Lab 2006;52: 115–24.Search in Google Scholar

14. Goldenberg NA, Hathaway WE, Jacobson L, Manco-Johnson MJ. A new global assay of coagulation and fibrinolysis. Thromb Res 2005;116:345–56.10.1016/j.thromres.2004.12.009Search in Google Scholar PubMed

15. Pinacho A, Paramo JA. Evaluation of fibrinolytic system in full-term neonates. Int J Clin Lab Res 1995;25:149–52.10.1007/BF02592557Search in Google Scholar PubMed

16. Reis M, Klingle J, Rauch R. In vitro fibrinolysis after adding low doses of plasminogen activators and plasmin generation with and without oxidative inactivation of plasmin inhinitors in newborns and adults. J Pediatr Hematol Oncol 1996;18:346–51.10.1097/00043426-199611000-00003Search in Google Scholar PubMed

17. Ignjatovic V, Kenet G, Monagle P. Developmental hemostasis: recommendations for laboratories reporting pediatric samples. J Thromb Haemost 2012;10:298–300.10.1111/j.1538-7836.2011.04584.xSearch in Google Scholar PubMed

Received: 2016-10-14
Accepted: 2016-12-27
Published Online: 2017-3-15
Published in Print: 2017-8-28

©2017 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 1.6.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2016-0931/html
Scroll to top button